Hassan Mahmoud (@hassan_mohamud) 's Twitter Profile
Hassan Mahmoud

@hassan_mohamud

Internist/Nephrologist @MaineMed | APD @MaineMed_IM_Res

ID: 352267507

linkhttps://www.twitter.com calendar_today10-08-2011 11:24:12

931 Tweet

278 Takipçi

641 Takip Edilen

Maine Med IM Residency Program (@mainemed_im_res) 's Twitter Profile Photo

It’s #ERAS season! Congratulations to everyone applying for residency this cycle. We are so excited to review applications & meet you! Here’s a peek into our timeline! #IMproud

It’s #ERAS season! Congratulations to everyone applying for residency this cycle. We are so excited to review applications & meet you! Here’s a peek into our timeline! #IMproud
Maine Med IM Residency Program (@mainemed_im_res) 's Twitter Profile Photo

Great discussion at this week’s #GrandRounds on Creating & Experiencing a Culture of Gratitude w/ Department of Medicine Chair Andy m Djamali, Chair of MaineHealth Maine Medical Center Board Amanda Rand, members of Leadership Gifts team Aislinn White, Cary Gemmer & Emily Smaldon #MedEd #Gratitude

Great discussion at this week’s #GrandRounds on Creating &amp; Experiencing a Culture of Gratitude w/ Department of Medicine Chair <a href="/adjamali/">Andy m Djamali</a>, Chair of <a href="/MaineMed/">MaineHealth Maine Medical Center</a> Board Amanda Rand, members of Leadership Gifts team Aislinn White, Cary Gemmer &amp; Emily Smaldon #MedEd #Gratitude
NEJM (@nejm) 's Twitter Profile Photo

Presented at #KidneyWk: Two years of empagliflozin slowed kidney disease progression or cardiovascular death. In a post-trial study, empagliflozin had additional cardiorenal benefits after discontinuation. Full post-trial study results: nej.md/3NE3W7K

Presented at #KidneyWk: 

Two years of empagliflozin slowed kidney disease progression or cardiovascular death. In a post-trial study, empagliflozin had additional cardiorenal benefits after discontinuation. Full post-trial study results: nej.md/3NE3W7K
NEJM (@nejm) 's Twitter Profile Photo

ALIGN: In a prespecified interim analysis of a phase 3, randomized, controlled trial, the selective endothelin type A receptor inhibitor atrasentan reduced proteinuria in patients with IgA nephropathy, without apparent safety issues. nej.md/3NzvISW #KidneyWk

ALIGN: In a prespecified interim analysis of a phase 3, randomized, controlled trial, the selective endothelin type A receptor inhibitor atrasentan reduced proteinuria in patients with IgA nephropathy, without apparent safety issues. nej.md/3NzvISW #KidneyWk
NEJM (@nejm) 's Twitter Profile Photo

Original Article: Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy (APPLAUSE-IgAN) nej.md/3UmrOkh Editorial: Waystations in Progress — Burgeoning Treatment Options for IgA Nephropathy nej.md/4fdz9dV #KidneyWk | American Society of Nephrology

Original Article: Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy (APPLAUSE-IgAN) nej.md/3UmrOkh 

Editorial: Waystations in Progress — Burgeoning Treatment Options for IgA Nephropathy nej.md/4fdz9dV 

#KidneyWk | <a href="/ASNKidney/">American Society of Nephrology</a>
NEJM (@nejm) 's Twitter Profile Photo

Presented at #KidneyWk: This study showed that both monoallelic and biallelic APOL1 risk variants were associated with higher odds of chronic kidney disease and focal segmental glomerulosclerosis. Full study results: nej.md/48qtlM0

Presented at #KidneyWk: 

This study showed that both monoallelic and biallelic APOL1 risk variants were associated with higher odds of chronic kidney disease and focal segmental glomerulosclerosis. Full study results: nej.md/48qtlM0
Gbadegesin Lab (@gbadegesinlab) 's Twitter Profile Photo

APOL1 variants and CKD in West Africa. One risk variant associated with FSGS and CKD. The story is getting more complex!! A call to sustain the momentum of cutting edge studies on APOL1 KD Opeyemi Olabisi Katalin Susztak SSC_Lab 🧬 Matt Sampson 🙏🏽

APOL1 variants and CKD in West Africa. One risk variant associated with FSGS and CKD. The story is getting more complex!! A call to sustain the momentum of cutting edge studies on APOL1 KD <a href="/OpeyemiOlabisi8/">Opeyemi Olabisi</a> <a href="/KSusztak/">Katalin Susztak</a> <a href="/SannaCherchiLab/">SSC_Lab 🧬</a> <a href="/kidneyomicsamps/">Matt Sampson</a> 🙏🏽
The Ohio State University Wexner Medical Center (@osuwexmed) 's Twitter Profile Photo

This week, #OSUWexMed completed a 10-way living kidney donation chain - one of the largest single institution chains in the United States to date. 20 people underwent surgery over two days, with Samantha, a non-directed donor, kicking things off. #Buckeye4Life